What is 9T Labs?
Founded in 2018 as a spin-off from the Federal Institute of Technology (ETH) in Zurich, 9T Labs is at the forefront of developing advanced 3D printing solutions for carbon composite parts. These materials, renowned for their exceptional strength-to-weight ratio, are critical for industries such as aerospace and medical devices. Traditional production methods for carbon composites are often resource-intensive and costly. 9T Labs' innovative 3D printing process aims to overcome these barriers, making high-performance materials more accessible and cost-effective. The company's technology promises to enhance manufacturing efficiency and open new application possibilities for lightweight, high-strength components.
How much funding has 9T Labs raised?
9T Labs has raised a total of $21.5M across 2 funding rounds:
Angel/Seed
$4.5M
Series A
$17M
Angel/Seed (2020): $4.5M, investors not publicly disclosed
Series A (2022): $17M led by Stratasys and Verve Ventures
Key Investors in 9T Labs
Stratasys
Stratasys, a pioneer in additive manufacturing solutions since 1989, provides advanced 3D printing technologies for design, manufacturing, and end-part production. Their investment in 9T Labs signals a strategic interest in the burgeoning field of advanced composite 3D printing.
Verve Ventures
Verve Ventures is a technology-driven venture capital firm specializing in early to growth-stage technology and science-driven startups across Europe. Their participation highlights a belief in 9T Labs' disruptive potential in the advanced materials sector.
What's next for 9T Labs?
With the recent strategic investment and substantial overall backing, 9T Labs is poised for significant growth and market penetration. The company's focus will likely be on scaling its production capabilities, finalizing the market launch of its 3D printer, and expanding its customer base within key industries like aerospace and medical technology. Further development of its printing technology and material science applications is also anticipated. This capital infusion will enable 9T Labs to solidify its position as a leader in the advanced composites additive manufacturing sector, driving innovation and adoption of its groundbreaking solutions.
See full 9T Labs company page
